Medicine and Dentistry
Radiation Therapy
100%
Pancreas Adenocarcinoma
83%
Pancreas Cancer
73%
Neoplasm
72%
Overall Survival
50%
Hepatocellular Carcinoma
38%
Computer Assisted Tomography
37%
Chemoradiotherapy
34%
Biological Marker
28%
Diseases
27%
Stereotactic Body Radiation Therapy
26%
Malignant Neoplasm
24%
Cholangiocarcinoma
23%
Surgery
23%
Intensity Modulated Radiation Therapy
20%
Cancer
17%
Neoadjuvant Therapy
17%
Pelvis
14%
Proton Therapy
14%
Metastatic Carcinoma
12%
Recurrent Disease
12%
Pancreaticoduodenectomy
12%
Quality of Life
12%
Anal Cancer
11%
Oncology
11%
Radiation Oncology
11%
Squamous Cell Carcinoma
11%
Re-Irradiation
11%
Image-Guided Intervention
11%
Gemcitabine
10%
Rectum Carcinoma
10%
Radiomics
10%
Progression Free Survival
10%
Systemic Therapy
10%
Pancreatectomy
10%
Clinical Trial
9%
Magnetic Resonance Imaging
9%
Hazard Ratio
9%
Diagnosis
9%
Paclitaxel
9%
Intraductal Papillary Mucinous Tumor
9%
Patient-Reported Outcome
9%
Rectum Cancer
9%
Arm
9%
Finite Element Analysis
9%
Anus
8%
Liver Cancer
8%
Solid Malignant Neoplasm
8%
External Beam Radiotherapy
8%
Adenocarcinoma
8%
Keyphrases
Pancreatic Ductal Adenocarcinoma
48%
Pancreatic Cancer
37%
Overall Survival
35%
Radiation Therapy
33%
Hepatocellular Carcinoma
28%
Chemoradiation
19%
Radiotherapy
19%
Tumor
18%
Chemotherapy
16%
Resectable Pancreatic Cancer
16%
Intensity-modulated Radiation Therapy
16%
Intrahepatic Cholangiocarcinoma (iCCA)
16%
Pancreatic Adenocarcinoma
14%
Neoadjuvant Therapy
14%
Stereotactic Body Radiation Therapy
14%
Liver
12%
Computed Tomography
11%
Dose Escalation
11%
Anal Cancer
11%
Re-irradiation
11%
Stereotactic Body Radiotherapy
11%
Pancreaticoduodenectomy
10%
Preoperative Therapy
10%
Local Control
10%
Squamous Cell Carcinoma of the Anus
10%
Pancreas
9%
Systemic Therapy
9%
Hyperfractionated
9%
Pancreatic Cyst
8%
Image Guidance
8%
Pancreatectomy
8%
Radiation Oncology
8%
Patient-reported Outcomes
7%
Lumican
7%
Confidence Interval
7%
Median Overall Survival
7%
Rectal Adenocarcinoma
6%
External Beam Radiotherapy
6%
Preoperative Chemotherapy
6%
United States
6%
Early Detection
6%
Proton Beam Therapy
6%
Hypofractionation
6%
Quality of Life
6%
Surgical Resection
6%
Pathologic
6%
Acute Toxicity
6%
Abdominal
6%
Clinical Trials
5%
Single Institution
5%